Key result
The incidence of surgical site infection after intertrochanteric fracture surgery was 1.3%, with gender, time to surgery >4 days, implant type, and albumin <35 g/L as independent risk factors.
Why the study?
Surgical site infection is a challenging complication after intertrochanteric fracture surgery, but large-sample size studies investigating its incidence and risk factors were lacking.
What is the incidence and what are the risk factors for surgical site infection after intertrochanteric fracture surgery?
Cohort (n=1,941)
What is the incidence and what are the risk factors for surgical site infection after intertrochanteric fracture surgery?
The incidence of surgical site infection after intertrochanteric fracture surgery is 1.3%, with gender, delayed surgery, implant type, and low albumin identified as independent risk factors.
May inform SSI risk stratification after intertrochanteric fracture surgery; hypothesis-generating and requires prospective validation before practice change.
Surgical site infection (SSI) is a challenging complication after intertrochanteric fracture surgery but without a large-sample size study to investigate the incidence and risk factors of it. The present study was to investigate the incidence and risk factors of SSI after intertrochanteric fracture surgery. A total of 1941 patients underwent intertrochanteric fracture surgery between October 2014 and December 2018 were included. Demographic data, surgical variables, and preoperative laboratory indexes were obtained from a prospective database and reviewed by hospital records. The optimum cut-off value for quantitative data was detected by receiver operating characteristic analysis. The univariate analysis and multivariable analysis were conducted to analyse the risk factors. In total, 25 patients (1.3%) developed SSI, including 22(1.1%) superficial infection and 3(0.2%) deep infection. After adjustment of multiple variables, gender (odds ratio[OR] 2.64, P = .024), time to surgery>4 days (OR 2.41, P = .046), implant (intramedullary or extramedullary devices) (OR 2.96, P = .036), ALB<35 g/L (OR 2.88, P = .031) remained significant factors. In conclusion, the incidence of SSI after intertrochanteric fractures surgery was 1.3%, with 1.1% for superficial and 0.2% for deep infection. Gender, time to surgery>4 days, the implant (intramedullary or extramedullary devices), and ALB<35 g/L were independent risk factors for the rate of SSI.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) conducted a cohort in Intertrochanteric fracture (n=1,941). Risk factors (gender, time to surgery >4 days, implant type, albumin <35 g/L) was evaluated on Surgical site infection (SSI). The incidence of surgical site infection after intertrochanteric fracture surgery was 1.3%, with gender, time to surgery >4 days, implant type, and albumin <35 g/L as independent risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: